Amgen executives detailed their alleged Aranesp "overfill" kickback scheme in a set of PowerPoint slides and Excel spreadsheets, according to a lawsuit filed by the New York State Attorney General.

WASHINGTON, Feb. 20 (UPI) -- Amgen shares slipped Friday after it was revealed a trial involving Aranesp was halted early due to an increased risk of recurrence of tumors in cancer patients ...

Biotech giant Amgen Inc. pleaded guilty in federal court to improper marketing of its anemia drug Aranesp and has agreed to pay $762 million in criminal fines and civil settlements to resolve ...

Swayed by a heap of clinical studies suggesting that Amgen ’s Aranesp and Johnson & Johnson ’s Procrit were potentially dangerous to cancer patients, the panel called on the FDA to expand the ...

Florida and 48 other states said today they reached a $71 million settlement with Amgen Inc. resolving allegations that Amgen unlawfully promoted the medications Aranesp and Enbrel. Aranesp is ...

Any good news is great news for Amgen these days. Shares of Amgen surged 7.3% on Thursday after the biotech company announced that Aranesp, its blockbuster anemia drug, didn't increase mortality ...

"Aranesp safety has evolved into the largest overhang on Amgen shares," Bear Stearns analyst Mark Schoenebaum said in a note to clients. "We view the neutral/positive 145 data as a major step ...

The anemia drugs epoetin alfa (Procrit and Epogen) and darbepoetin alfa (Aranesp) are among the top-sellers in the U.S., as consumers and their insurance companies spent $7.2 billion in 2008 on ...

In the Phase 3 head-to-head study, a total of 1,220 patients with chemotherapy-induced anemia were randomized to receive either Aranesp 200 mcg every two weeks (n=613) or Epoetin alfa 40,000 U ...

the anemia treatment Aranesp. After the closing bell, Thousand Oaks, Calif.-based Amgen AMGN reported net income for the three-month period ended Sept. 30 of $1.1 billion, or 94 cents a share ...

This leaflet answers some common questions about Aranesp (darbepoetin alfa). It does not contain all the available information. It does not take the place of talking to your doctor, nurse or ...